OCT 9·SEC EDGARLow
Wichterman Troy sold (to issuer) 256,000 shares of BLFS
Wichterman Troy (Chief Financial Officer) sold (to issuer) 256,000 shares of BIOLIFE SOLUTIONS INC (BLFS) on 2026-10-06.
StockDelisted · Oct 2026NASDAQ · US · USDHealthcare · Medical Instruments & Supplies
$BLFS
BIOLIFE SOLUTIONS INC
AlphAI earnings readSecond Quarter 2026 · AUG 6Total revenue of $28.5 million, up 21% over Q2 2025; GAAP net income of $45.1 million included a $42.4 million non-cash income tax benefit; adjusted EBITDA was $7.4 million, or 26% of revenue.Verdict: strongRead →
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
Price · $BLFSvia TradingView
AI sentiment · 7d0 articles
No enriched coverage for $BLFS in the last 7 days.
Insider · 30dAll trades →
- Buys
- — 0 txs
- Sells
- — 11 txs
Coste Catherine1× · —
10b5-1 share of filings0%
Top stories · $BLFSMore →
OCT 9·SEC EDGAR
GOSWAMI JOYDEEP sold (to issuer) 53,156 shares of BLFS
GOSWAMI JOYDEEP sold (to issuer) 53,156 shares of BIOLIFE SOLUTIONS INC (BLFS) on 2026-10-06.
OCT 9·stocktitan.net
BioLife Solutions director disposes of 57,995 shares
BioLife Solutions director Rachel Ellingson sold 57,995 shares on October 6, 2026, as part of a merger with Repligen. Each share was converted to $11.25 in cash and 0.1442 Repligen shares, per the merger agreement. Ellingson held no shares post-transaction.
BLFS sentiment & insider activity
Recent BLFS coverage spans insider activity and financial news.
In the last 30 days, BLFS insiders filed 11 SEC Form 4 transactions — no purchases and 11 sales. The most active reporter was Coste Catherine with 1 filing.
What's driving BLFS
The insider sale may signal reduced confidence from the CFO, but no price was disclosed.
Insider director exited all positions, suggesting possible negative sentiment.
BioLife Solutions director Rachel Ellingson sold 57,995 shares on October 6, 2026, as part of a merger with Repligen. Each share was converted to $11.25 in cash and 0.1442 Repligen shares, per the merger agreement. Ellingson held no shares post-transaction.
The insider sale may signal slight negative sentiment but the modest size limits impact.
The insider sale may signal reduced confidence from a director, potentially pressuring the stock.
AlphAI scores every news story that mentions BLFS with an AI model for sentiment and relevance, and aggregates insider trades from BIOLIFE SOLUTIONS INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
News on $BLFS
Score
Wichterman Troy sold (to issuer) 256,000 shares of BLFS
Wichterman Troy (Chief Financial Officer) sold (to issuer) 256,000 shares of BIOLIFE SOLUTIONS INC (BLFS) on 2026-10-06.
1 min readGOSWAMI JOYDEEP sold (to issuer) 53,156 shares of BLFS
GOSWAMI JOYDEEP sold (to issuer) 53,156 shares of BIOLIFE SOLUTIONS INC (BLFS) on 2026-10-06.
1 min readBioLife Solutions director disposes of 57,995 shares
BioLife Solutions director Rachel Ellingson sold 57,995 shares on October 6, 2026, as part of a merger with Repligen. Each share was converted to $11.25 in cash and 0.1442 Repligen shares, per the merger agreement. Ellingson held no shares post-transaction.
1 min readEllingson Rachel sold (to issuer) 57,995 shares of BLFS
Ellingson Rachel sold (to issuer) 57,995 shares of BIOLIFE SOLUTIONS INC (BLFS) on 2026-10-06.
1 min readDuRoss Amy sold (to issuer) 26,857 shares of BLFS
DuRoss Amy sold (to issuer) 26,857 shares of BIOLIFE SOLUTIONS INC (BLFS) on 2026-10-06.
1 min readBioLife Solutions director disposes of 13,871 shares
BioLife Solutions director Catherine Coste sold 13,871 shares on October 6, 2026, as part of a merger with Repligen. Under the merger terms, each BioLife share converted to $11.25 in cash and 0.1442 Repligen shares, per the merger agreement.
1 min readCoste Catherine sold (to issuer) 13,871 shares of BLFS
Coste Catherine sold (to issuer) 13,871 shares of BIOLIFE SOLUTIONS INC (BLFS) on 2026-10-06.
1 min readDE GREEF RODERICK sold (to issuer) 826,454 shares of BLFS
DE GREEF RODERICK (Chief Executive Officer) sold (to issuer) 826,454 shares of BIOLIFE SOLUTIONS INC (BLFS) on 2026-10-06.
1 min readHunt Anthony sold (to issuer) 15,046 shares of BLFS
Hunt Anthony sold (to issuer) 15,046 shares of BIOLIFE SOLUTIONS INC (BLFS) on 2026-10-06.
1 min readMOORE TIMOTHY L. sold (to issuer) 44,943 shares of BLFS
MOORE TIMOTHY L. sold (to issuer) 44,943 shares of BIOLIFE SOLUTIONS INC (BLFS) on 2026-10-06.
1 min read